Sign up
Log in
SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of National HealthCare Corporation (NYSE: NHC) and Encourages Long-Term NHC Investors to Contact the Firm
Share
Listen to the news

PHILADELPHIA, July 10, 2025 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating National HealthCare Corporation (NYSE: NHC) ("NHC") on behalf of the company's long-term investors. 

Since November 2024, shares of NHC's common stock have declined in value from a trading price of over $135.00 per share to a current trading price of below $110.00 per share, a decline of nearly 20% in value. 

The investigation seeks to determine whether NHC and/or the company's officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. 

NHC shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about this investigation and their legal rights and options at (484) 229 – 0750, or by clicking on the following link (or by copying and pasting the link into your browser): 

https://kaskelalaw.com/cases/national-healthcare-corp/ 

 

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com

CONTACT: 

KASKELA LAW LLC 

D. Seamus Kaskela, Esq. 

(skaskela@kaskelalaw.com

Adrienne Bell, Esq. 

(abell@kaskelalaw.com

18 Campus Blvd., Suite 100 

Newtown Square, PA 19073 

(484) 229 – 0750 

www.kaskelalaw.com 

This notice may constitute attorney advertising in certain jurisdictions. 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-notice-kaskela-law-llc-announces-shareholder-investigation-of-national-healthcare-corporation-nyse-nhc-and-encourages-long-term-nhc-investors-to-contact-the-firm-302501866.html

SOURCE Kaskela Law LLC

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.